Veradermics MANE
NYSE MANE
$148.63 +4.68 (+3.25%)
As of: Nov 10, 2026 · 3:59 PM EST

Veradermics (MANE) Assets (2024 - 2026)

Updated

Veradermics (MANE) reported Assets of $825.74 million for Q2 2026, up 107.8% from the prior quarter.

Analysis

Veradermics (MANE) Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Veradermics posted Assets of $152.62 million, up 174.8% from FY2024.

  • By year, Assets came in at $55.54 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 197.43 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 147.68 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 115.83 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 51.41 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 205.00 Bn
10 Veradermics 6.01 Bn 4.61 Bn - 825.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 825.74 Mn
Mar 31, 2026 397.36 Mn
Dec 31, 2025 152.62 Mn
Dec 31, 2024 55.54 Mn
API Access

Veradermics Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=MANE&period=max&api_key=YOUR_API_KEY